Clinical outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventions later than 48 h after symptom onset

Author:

Rohla Miklos1ORCID,Temperli Fabrice1,Siontis George C M1,Klingenberg Roland2,Gencer Baris34,Rodondi Nicolas45ORCID,Bär Sarah1ORCID,Nanchen David6,Mach Francois3,Häner Jonas D1,Pilgrim Thomas1ORCID,Muller Olivier7ORCID,Matter Christian M2,Lüscher Thomas89,Roffi Marco3ORCID,Heg Dik10,Windecker Stephan1ORCID,Räber Lorenz1ORCID

Affiliation:

1. Department of Cardiology, Bern University Hospital, Inselspital, University of Bern , Freiburgstrasse 18, 3010 Bern , Switzerland

2. Department of Cardiology, University Heart Center, University Hospital Zürich , Rämistrasse 100, 8091 Zürich , Switzerland

3. Division of Cardiology, Faculty of Medicine, Geneva University Hospitals , Rue Gabrielle-Perret-Gentil 4, 1205 Genève , Switzerland

4. Institute of Primary Health Care (BIHAM), University of Bern , Mittelstrasse 43, 3012 Bern , Switzerland

5. Department of General Internal Medicine, Bern University Hospital, University of Bern , Freiburgstrasse 18, 3010 Bern , Switzerland

6. Center for Primary Care and Public Health (Unisanté), University of Lausanne , Rue du Bugnon 44, 1011 Lausanne , Switzerland

7. Department of Cardiology, University Hospital of Lausanne, University of Lausanne , Rue du Bugnon 46, 1011 Lausanne , Switzerland

8. Royal Brompton & Harefield Hospital GSTT and Imperial College and King’s College, London , 1 Manresa Rd, London SW3 6LR , UK

9. Center for Molecular Cardiology, University of Zürich , Wagistrasse 12, 8952 Schlieren , Switzerland

10. Clinical Trial Unit, University of Bern , Mittelstrasse 43, 3012 Bern , Switzerland

Abstract

Abstract Aims Routine revascularization in patients with ST-segment elevation myocardial infarction (STEMI) presenting >48 h after symptom onset is not recommended. Methods and results We compared outcomes of STEMI patients undergoing percutaneous coronary intervention (PCI) according to total ischaemic time. Patients included in the Bern-PCI registry and the Multicenter Special Program University Medicine ACS (SPUM-ACS) between 2009 and 2019 were analysed. Based on symptom-to-balloon-time, patients were categorized as early (<12 h), late (12–48 h), or very late presenters (>48 h). Co-primary endpoints were all-cause mortality and target lesion failure (TLF), a composite of cardiac death, target vessel myocardial infarction, and target lesion revascularization at 1 year. Of 6589 STEMI patients undergoing PCI, 73.9% were early, 17.2% late, and 8.9% very late presenters. The mean age was 63.4 years, and 22% were female. At 1 year, all-cause mortality occurred more frequently in late vs. early [5.8 vs. 4.4%, hazard ratio (HR) 1.34, 95% confidence interval (CI) 1.01–1.78, P = 0.04] and very late (6.8%) vs. early presenters (HR 1.59, 95% CI 1.12–2.25, P < 0.01). There was no excess in mortality comparing very late and late presenters (HR 1.18, 95% CI 0.79–1.77, P = 0.42). Target lesion failure was more frequent in late vs. early (8.3 vs. 6.5%, HR 1.29, 95% CI 1.02–1.63, P = 0.04) and very late (9.4%) vs. early presenters (HR 1.47, 95% CI 1.09–1.97, P = 0.01), and similar between very late and late presenters (HR 1.14, 95% CI 0.81–1.60, P = 0.46). Following adjustment, heart failure, impaired renal function, and previous gastrointestinal bleeding, but not treatment delay, were the main drivers of outcomes. Conclusion PCI >12 h after symptom onset was associated with less favourable outcomes, but very late vs. late presenters did not have an excess in events. While benefits seem uncertain, (very) late PCI appeared safe.

Funder

Swiss National Science Foundation

AstraZeneca

Medtronic

Eli Lilly

Zurich Heart House

Foundation of Cardiovascular Research

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3